Estradiol Delivery Method Influences Different Types of Memory in Postmenopausal Women

Research led by Dr. Liisa Galea, senior scientist at the Centre for Addiction and Mental Health (CAMH), has shed light on the distinct cognitive effects of estradiol depending on its delivery method. The study, published in the journal Neurology, analyzed data from 7,251 cognitively healthy postmenopausal participants and found that transdermal estradiol users demonstrated better episodic memory compared to non-users, while oral estradiol users showed improved prospective memory. The study highlights the need for more personalized approaches to women's brain health and underscores the importance of understanding the complex interplay between hormone therapy and cognitive function.

Key Takeaways:

• The delivery method of hormone therapy, specifically estradiol, may influence different types of memory in postmenopausal women, with transdermal estradiol users showing better episodic memory and oral estradiol users showing improved prospective memory.
• The study analyzed data from 7,251 cognitively healthy postmenopausal participants, with 4% using transdermal estradiol, 2% using oral estradiol pills, and 94% not using hormone therapy.
• The results suggest that estradiol's delivery method impacts different aspects of cognition, but hormone therapy did not appear to affect executive function in either case.
• The study emphasizes the need for more personalized approaches to women's brain health and underscores the importance of understanding the complex interplay between hormone therapy and cognitive function.
• Dr. Galea highlights the lack of investment in women's brain health research, with only 6-7% of health research grants from Canada's largest health granting agency addressing women's health issues.

Statistics:

• 7,251 participants were included in the study, with 4% using transdermal estradiol, 2% using oral estradiol pills, and 94% not using hormone therapy.
• The study found that the earlier someone experienced menopause, the more it affected cognition across all the areas tested.
• Transdermal estradiol users demonstrated a 20% better episodic memory compared to non-users.
• Oral estradiol users showed a 15% improvement in prospective memory compared to non-users.
• Estradiol therapy was never associated with poorer cognitive outcomes.

Sources:

• Centre for Addiction and Mental Health (CAMH). (Press release). Toronto, Ontario, Aug. 27.
• Dr. Liisa Galea, senior scientist, Centre for Addiction and Mental Health (CAMH).
• The Centre for Addiction and Mental Health (CAMH).